Latest Insider Transactions at Denali Therapeutics Inc. (DNLI)
This section provides a real-time view of insider transactions for Denali Therapeutics Inc. (DNLI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Denali Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Denali Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 12
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
5,102
+0.95%
|
$25,510
$5.28 P/Share
|
|
Feb 15
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,476
-0.8%
|
$42,804
$29.4 P/Share
|
|
Feb 13
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
33,815
-0.75%
|
$1,014,450
$30.09 P/Share
|
|
Feb 13
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
25,000
+1.09%
|
$0
$0.68 P/Share
|
|
Feb 13
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
3,497
-0.66%
|
$104,910
$30.09 P/Share
|
|
Feb 13
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
25,000
+4.55%
|
$0
$0.68 P/Share
|
|
Feb 13
2023
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,119
-1.46%
|
$63,570
$30.1 P/Share
|
|
Feb 13
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,548
-1.36%
|
$76,440
$30.1 P/Share
|
|
Feb 10
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
818
-0.45%
|
$23,722
$29.8 P/Share
|
|
Feb 10
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-1.11%
|
$725,000
$29.1 P/Share
|
|
Feb 10
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
25,000
+1.1%
|
$0
$0.68 P/Share
|
|
Feb 09
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
3,433
-0.15%
|
$102,990
$30.59 P/Share
|
|
Feb 08
2023
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,377
-0.94%
|
$41,310
$30.88 P/Share
|
|
Feb 08
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
1,521
-0.3%
|
$45,630
$30.89 P/Share
|
|
Feb 08
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,521
-0.84%
|
$45,630
$30.88 P/Share
|
|
Jan 17
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.99%
|
$290,000
$29.7 P/Share
|
|
Jan 17
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+1.93%
|
$50,000
$5.28 P/Share
|
|
Jan 09
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,459
-0.82%
|
$40,852
$28.48 P/Share
|
|
Jan 06
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,451
-0.8%
|
$40,628
$28.67 P/Share
|
|
Jan 05
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
4,800
-0.22%
|
$134,400
$28.44 P/Share
|
|
Jan 05
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,636
-0.53%
|
$73,808
$28.44 P/Share
|
|
Jan 05
2023
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,970
-1.99%
|
$83,160
$28.44 P/Share
|
|
Jan 05
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,636
-1.44%
|
$73,808
$28.44 P/Share
|
|
Jan 04
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
5,029
-0.23%
|
$140,812
$28.73 P/Share
|
|
Jan 04
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,912
-1.91%
|
$81,536
$28.7 P/Share
|
|
Jan 04
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,913
-1.63%
|
$81,564
$28.69 P/Share
|
|
Jan 03
2023
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
82,240
+26.18%
|
-
|
|
Jan 03
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
41,120
+20.69%
|
-
|
|
Jan 03
2023
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,120
+22.83%
|
-
|
|
Nov 23
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.06%
|
$600,000
$30.48 P/Share
|
|
Nov 02
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
11,252
-0.59%
|
$337,560
$30.33 P/Share
|
|
Nov 01
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
8,748
-0.46%
|
$262,440
$30.2 P/Share
|
|
Oct 07
2022
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,000
+3.94%
|
$0
$0.68 P/Share
|
|
Sep 28
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.52%
|
$600,000
$30.91 P/Share
|
|
Aug 23
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.51%
|
$640,000
$32.02 P/Share
|
|
Aug 23
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,424
-1.4%
|
$75,144
$31.98 P/Share
|
|
Aug 19
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
2,404
-0.11%
|
$79,332
$33.22 P/Share
|
|
Aug 19
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,253
-1.49%
|
$74,349
$33.22 P/Share
|
|
Aug 19
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,576
-0.55%
|
$85,008
$33.22 P/Share
|
|
Aug 19
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,576
-1.47%
|
$85,008
$33.22 P/Share
|
|
Aug 09
2022
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+16.91%
|
-
|
|
Aug 09
2022
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+15.63%
|
-
|
|
Jul 25
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.51%
|
$700,000
$35.88 P/Share
|
|
Jul 19
2022
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+29.18%
|
$0
$0.68 P/Share
|
|
Jun 24
2022
|
Marc Tessier Lavigne Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,750
-1.16%
|
$1,402,500
$30.81 P/Share
|
|
Jun 23
2022
|
Marc Tessier Lavigne Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,250
-0.65%
|
$410,750
$31.1 P/Share
|
|
Jun 02
2022
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+41.33%
|
-
|
|
Jun 02
2022
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,986
+1.75%
|
-
|
|
Jun 02
2022
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+34.6%
|
-
|
|
Jun 02
2022
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+4.04%
|
-
|